Agger Mette Kirstine has filed 7 insider transactions across 2 companies since February 2024.
Most recent transaction: a disposition of 19750 shares of scPharmaceuticals Inc. ($SCPH) on October 07, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Agger Mette Kirstine | Not found | D | Stock Option (Right to Buy) | 19750 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.04% |
| Oct. 7, 2025 | scPharmaceuticals Inc. | $SCPH | Agger Mette Kirstine | Not found | D | Stock Option (Right to Buy) | 30000 | $0.00 | 0.0000 | 53,719,662 | 100.00% | 0.06% |
| June 26, 2025 | Lexeo Therapeutics, Inc. | $LXEO | Agger Mette Kirstine | Not found | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 33,196,997 | 9999.99% | 0.08% |
| June 3, 2025 | scPharmaceuticals Inc. | $SCPH | Agger Mette Kirstine | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 44,519,669 | 9999.99% | 0.07% |
| June 25, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Agger Mette Kirstine | Not found | A | Stock Option (right to buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | scPharmaceuticals Inc. | $SCPH | Agger Mette Kirstine | Not found | A | Stock Option (Right to Buy) | 19750 | $0.00 | 19,750.0000 | 38,513,747 | 9999.99% | 0.05% |
| Feb. 2, 2024 | Lexeo Therapeutics, Inc. | $LXEO | Agger Mette Kirstine | Director | A | Stock Option (right to buy) | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |